Recombinant Neurospora crassa Protein CSN12 homolog (csn-12)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for fulfillment according to your needs.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a useful guideline.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during the production process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
csn-8; csn12; NCU08388; Protein CSN12 homolog; COP9 signalosome protein 8
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-461
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987)
Target Names
csn-8
Target Protein Sequence
MDSLIRTFSN AQSSRDGYQL AQTLSPDLPQ QQLQAIWKSC GHHDAQNVIK RGIQNSTSGF EKLPKDEVQG WSDVYLAYWK AIGELLPALN QAPQSSWTKV YDAWKELLSA LYRGYIGQGF EAWSIPCLYV VAKNLRFFAL KADEERNNNV AAGDTSGQIF QDDFDPESEQ NQKLEDCARQ LNRIFTLCLN DRAPLEESRK WGIYYIINLL FKTYFKLNSA SLSKNILKTL SAYRGDMPPL SAFPKSQQVT FKYYEGVLCF LEENYFQAEE HLTQAWSLCH KDAMKNKELI LTYLVPCHLL TTHTLPSQKL LEPYPRLQKL FLPLSNCIKK GELHAFDLAL QQGEDEFVKR RIYLTLERGR DIALRNLLRK VFIAGGFEES KVEGGPRVRR TRIPVAEFAA AISLGSKQML ETDEIECLMA NMIYKLVTNQ SGIKNLMKGY IARERGFVVL SKSGAFPGTG V
Uniprot No.

Q&A

What is the COP9 signalosome complex and how does CSN-12 fit within this structure?

The COP9 signalosome (CSN) is an evolutionarily conserved multifunctional complex that regulates ubiquitin-dependent protein degradation in eukaryotes . This complex plays crucial roles in various cellular processes including growth, development, and circadian rhythm regulation. Seven CSN subunits have been identified in Neurospora crassa through previous studies . CSN-12 represents one of these subunits, though it appears to have distinctive roles compared to other components like CSN-1 through CSN-7, which have been more extensively characterized. The complex functions to control cullin-RING ubiquitin ligase (CRL) activity through deneddylation processes, removing the Nedd8/Rub1 modification from cullin proteins.

How does CSN-12 in Neurospora crassa compare to homologs in other model organisms?

Based on comparative analyses, CSN-12 in Neurospora crassa shares functional and structural similarities with Csn12 in Saccharomyces cerevisiae . In yeast, Csn12 has been shown to interact with Thp3 to form a complex independent of other CSN subunits . This interaction appears important for functions beyond the typical CRL regulation performed by most CSN components. Unlike other CSN subunits in yeast, deletion of Csn12 does not lead to accumulation of neddylated Cdc53, suggesting a distinctive role . Additionally, yeast Csn12 uniquely interacts with proteins involved in mRNA splicing (SMB1, SMX2, and SMX3), potentially linking this subunit to RNA processing mechanisms . These comparative insights provide valuable context for understanding the potential unique functions of CSN-12 in Neurospora crassa.

What techniques are commonly used to study CSN-12 in fungal systems?

Research on CSN-12 and related subunits in fungi typically employs a complementary set of molecular and biochemical approaches. Gene knockout methodologies are fundamental, allowing researchers to create csn-12 deletion mutants to observe resulting phenotypes . Protein expression and purification techniques, including recombinant expression in E. coli using vectors like pET-22b with C-terminal 6×His tags, enable isolation of the protein for biochemical studies . Co-immunoprecipitation and tandem affinity purification (TAP) are valuable for identifying protein-protein interactions, as demonstrated in studies showing Thp3 co-enrichment with TAP-tagged Csn12 in yeast . Additional approaches include western blotting to examine protein stability and modification states (particularly cullin neddylation), phenotypic characterization of mutants, and structural studies through crystallography to understand complex formation with interacting partners.

What purification strategy yields the highest purity and activity for recombinant CSN-12?

A multi-step purification strategy is recommended to obtain high-purity, active CSN-12. Based on protocols used for similar proteins, begin with immobilized metal affinity chromatography (IMAC) using Ni-NTA resin for initial capture of His-tagged CSN-12 . The cell lysate should be prepared in a buffer containing approximately 50 mM Tris (pH 8.0-8.7) and 500 mM NaCl . After binding, perform sequential washes with increasing imidazole concentrations (20 mM and 50 mM) before eluting the protein with 300 mM imidazole . Further purification steps should include size exclusion chromatography to separate monomeric protein from aggregates, followed by ion exchange chromatography (preferably cation exchange) for removing remaining contaminants . For complex formation studies, co-purification with interaction partners may be necessary to maintain stability. Throughout the purification process, include protease inhibitors and maintain cold temperatures (4°C) to minimize degradation.

How can researchers effectively generate and validate knockout mutants of csn-12 in Neurospora crassa?

To generate csn-12 knockout mutants in Neurospora crassa, researchers should employ homologous recombination-based gene replacement strategies. This involves designing constructs containing a selectable marker (typically hygromycin resistance) flanked by sequences homologous to regions upstream and downstream of the csn-12 gene . The construct is then transformed into N. crassa conidia using standard methods such as electroporation or polyethylene glycol-mediated transformation. For validation, several complementary approaches are essential: PCR analysis with primers specific to regions outside the recombination sites to confirm proper integration; Southern blotting to verify correct insertion and gene deletion; and RT-PCR or quantitative PCR to ensure absence of csn-12 mRNA expression . Additionally, western blotting with antibodies against CSN-12 can confirm absence of the protein. Phenotypic characterization focusing on growth patterns, conidiation, circadian rhythms, and cullin neddylation states should be performed to assess functional consequences of the deletion, as has been done for other CSN subunits .

What protein-protein interactions involve CSN-12, and how do they affect its function?

Based on studies of the yeast homolog Csn12, CSN-12 likely participates in several important protein-protein interactions that influence its function. In yeast, Csn12 specifically interacts with Thp3 to form a complex independent of other CSN subunits . Mass spectrometry-based protein interaction analysis has confirmed this association, with Thp3 co-enriching with tandem affinity purification (TAP)-tagged Csn12 . Additionally, yeast Csn12 uniquely interacts with splicing factors including SMB1, SMX2, and SMX3, suggesting a potential role in mRNA processing . In the context of complex formation, Csn12 can also interact with Sem1 to form a ternary complex with Thp3 . These interactions suggest that CSN-12 may serve as a bridge between the CSN complex and RNA processing machinery. To characterize these interactions in N. crassa specifically, researchers should employ co-immunoprecipitation studies followed by mass spectrometry analysis, yeast two-hybrid screens, or proximity labeling approaches using CSN-12 as bait.

How does the CSN-12 subunit contribute to the stability of various E3 ubiquitin ligase complexes?

Research on other CSN subunits in N. crassa provides a framework for investigating CSN-12's contribution to E3 ubiquitin ligase stability. CSN-1, CSN-2, CSN-4, CSN-5, CSN-6, and CSN-7 are essential for maintaining the stability of Cul1 in SCF complexes and Cul3 and BTB proteins in Cul3-BTB E3s . Five of these subunits (excluding CSN-3 and CSN-5) are required for maintaining SKP-1 stability in SCF complexes . All seven known CSN subunits are necessary for Cul4-DDB1 complex stability . CSN-3 specifically maintains the stability of CSN-2 and FWD-1 in SCF(FWD-1) complexes . To determine CSN-12's role in this context, researchers should conduct stability assays using cycloheximide chase experiments in wild-type and csn-12 deletion strains, examining the degradation rates of various E3 ligase components through western blotting. Co-immunoprecipitation studies could reveal whether CSN-12 directly interacts with these complexes. Additionally, examining ubiquitination levels of known substrates of different E3 ligases would provide functional insights into how CSN-12 affects the ubiquitin-proteasome system.

What is the structural basis for CSN-12's interaction with the Thp3-Sem1 complex, and how does this relate to function?

Drawing from studies on yeast proteins, the structural relationship between CSN-12 and a Thp3-Sem1 complex likely involves specific domain interactions that facilitate complex formation. In yeast, researchers have attempted to crystallize the Thp3-Csn12-Sem1 ternary complex, though obtaining diffraction-quality crystals proved challenging due to flexible regions in the proteins . Secondary structure prediction and multiple sequence alignment indicate that Thp3 contains a divergent, flexible N-terminal region followed by highly conserved middle and C-terminal regions, while Csn12 presents regular secondary structures . The interaction likely involves PCI (Proteasome, COP9, eIF3) domains, which are common in proteins of the CSN complex and related assemblies . To elucidate this structural relationship in N. crassa proteins, researchers should employ a combination of:

  • Truncation experiments to identify the minimal interacting domains

  • Site-directed mutagenesis of conserved residues to pinpoint key interaction sites

  • Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

  • Cryo-electron microscopy for structural determination of the entire complex

Understanding this structural basis would provide insights into how CSN-12 might coordinate between CSN complex functions and RNA processing activities.

What is the evolutionary relationship between CSN-12 and other PCI domain-containing proteins across different species?

The evolutionary relationship between CSN-12 and other PCI domain-containing proteins reflects the conservation and specialization of these proteins across species. PCI domain proteins play important roles in post-transcriptional gene regulation, as seen in both the TREX-2 complex and the COP9 signalosome . In the TREX-2 complex, PCI domain-containing Sac3 and Thp1 proteins form a complex with the accessory Sem1 protein to facilitate mRNA nuclear export . Similarly, in the COP9 signalosome, several subunits contain PCI domains that contribute to complex assembly and function. CSN-12 likely represents a specialized evolution of these domains for specific functions related to both protein degradation and RNA processing.

To comprehensively analyze this evolutionary relationship, researchers should:

  • Perform phylogenetic analyses of CSN-12 homologs across fungal, plant, and animal kingdoms

  • Compare sequence conservation specifically within PCI domains

  • Analyze synteny of genes encoding CSN-12 homologs to identify structural genomic conservation

  • Conduct functional complementation studies to determine if CSN-12 from different species can rescue phenotypes in N. crassa csn-12 mutants

This evolutionary perspective would provide insights into the functional diversification of CSN-12 and its role in coordinating multiple cellular processes.

What are the common challenges in expressing and purifying recombinant CSN-12, and how can they be overcome?

Researchers working with CSN-12 and its homologs have encountered several challenges during recombinant expression and purification. Studies on the yeast homolog Csn12 revealed that when expressed individually, it tends to form multimers and exhibits instability in solution . This makes obtaining sufficient quantities for biochemical studies difficult. To overcome these challenges:

  • Protein instability: Co-express CSN-12 with its interaction partners like the N. crassa equivalents of Thp3 and Sem1. For example, use pETDuet-1 vectors to clone 6×His-tagged CSN-12 and untagged partners in the first and second multiple cloning sites, respectively .

  • Protein solubility: Optimize expression conditions by lowering induction temperature (16-18°C), reducing IPTG concentration, and including solubility enhancers like sorbitol or glycerol in the growth medium.

  • Purification difficulties: Implement a multi-step purification strategy including Ni-NTA affinity chromatography with optimized imidazole concentration gradients (20 mM, 50 mM washes, 300 mM elution), followed by size exclusion and ion exchange chromatography .

  • Protein aggregation: Include reducing agents like DTT or β-mercaptoethanol in all buffers, and optimize buffer conditions (pH, salt concentration) based on CSN-12's theoretical isoelectric point.

These approaches should allow for successful production of functional protein for subsequent analyses.

How can researchers effectively analyze the impact of CSN-12 on cullin neddylation states?

  • Sample preparation: Extract proteins from wild-type, csn-12 knockout, and other csn subunit knockout strains of N. crassa under identical conditions to enable direct comparisons. Use lysis buffers containing deubiquitinating enzyme inhibitors and NEDD8 isopeptidase inhibitors to preserve in vivo modification states.

  • Gel electrophoresis optimization: Use low-percentage (6-8%) SDS-PAGE gels to adequately separate the neddylated (higher molecular weight) and unneddylated forms of cullins, which typically differ by only ~9 kDa.

  • Immunoblotting approach: Employ antibodies specific to N. crassa cullins (Cul1, Cul3, Cul4) or use epitope-tagged cullin versions if specific antibodies are unavailable. Alternatively, anti-NEDD8 antibodies can detect all neddylated proteins.

  • Quantitative analysis: Use densitometry to quantify the ratio of neddylated to unneddylated cullins as a measure of CSN activity. Compare these ratios across different strains to determine CSN-12's specific contribution.

  • Controls: Include samples from strains with deletions of known deneddylation-critical subunits (like CSN-5) as positive controls for neddylation accumulation .

This methodical approach will reveal whether CSN-12 impacts cullin neddylation similarly to other CSN subunits or has a distinctive role.

How should researchers interpret phenotypic differences between csn-12 mutants and other csn subunit mutants?

When interpreting phenotypic differences between csn-12 mutants and other csn subunit mutants, researchers should apply a systematic framework that considers both mechanistic and functional implications. Studies of CSN subunits in N. crassa have shown that deletions of CSN-1, CSN-2, CSN-4, CSN-5, CSN-6, and CSN-7 result in severe phenotypic defects, while CSN-3 deletion surprisingly shows a wild-type phenotype . These differences reflect the functional specialization of CSN subunits.

For proper interpretation:

  • Categorize observed phenotypes: Group phenotypes into categories related to growth, development, circadian rhythm, stress responses, and molecular parameters like cullin neddylation states.

  • Establish a phenotypic severity scale: Create a quantitative scoring system to objectively compare severity across mutants. For example:

    PhenotypeWild-typeCSN-3ΔCSN-1Δ through CSN-7ΔCSN-12Δ
    Growth rate+++++++?
    Conidiation+++++++?
    Circadian rhythm+++++++?
    Cullin deneddylation+++++++?
  • Correlate molecular and phenotypic data: Examine whether changes in cullin neddylation correlate with specific phenotypes, which would suggest direct CSN-mediated effects, versus phenotypes that appear independent of neddylation status, suggesting alternative functions.

  • Consider genetic interactions: Perform double mutant analyses between csn-12 and other csn subunits to determine epistatic relationships that could reveal functional pathways.

This framework allows researchers to determine whether CSN-12 functions primarily within the canonical CSN complex or has independent roles similar to what has been observed for CSN-3 or the yeast Csn12 homolog.

What statistical approaches are most appropriate for analyzing protein-protein interaction data involving CSN-12?

When analyzing protein-protein interaction data for CSN-12, researchers should employ robust statistical approaches appropriate for different experimental methods. For mass spectrometry-based interaction studies similar to those used to identify Thp3 interaction with Csn12 in yeast , the following statistical frameworks are recommended:

  • For AP-MS/TAP-MS experiments:

    • Implement Significance Analysis of INTeractome (SAINT) algorithm to assign confidence scores to protein-protein interactions

    • Apply false discovery rate (FDR) control using target-decoy approach with a recommended cutoff of ≤1%

    • Use Contaminant Repository for Affinity Purification (CRAPome) database to filter common contaminants

  • For proximity labeling approaches (BioID, APEX):

    • Apply fold-change enrichment calculations with minimum thresholds of >2-fold enrichment

    • Implement multiple hypothesis testing correction (Benjamini-Hochberg procedure)

    • Consider volcano plot visualization with enrichment ratio vs. statistical significance

  • For co-immunoprecipitation with immunoblotting:

    • Perform densitometry quantification across multiple biological replicates (n≥3)

    • Apply paired t-tests or non-parametric alternatives (Wilcoxon signed-rank test)

    • Calculate effect sizes (Cohen's d) to estimate interaction strength

  • For network analysis:

    • Apply modularity algorithms to identify protein complexes

    • Use centrality measures (degree, betweenness) to identify hub proteins

    • Implement permutation-based methods to assess network significance

These statistical approaches should be accompanied by appropriate controls, including negative controls (non-specific antibodies, unrelated baits) and positive controls (known interaction partners) to establish confidence thresholds.

What are the most promising approaches to study CSN-12's potential role in RNA processing mechanisms?

Given the yeast homolog Csn12's interaction with splicing factors , investigating CSN-12's potential role in RNA processing in N. crassa represents an exciting research direction. The most promising approaches include:

  • Transcriptome-wide analysis: Apply RNA sequencing to compare wild-type and csn-12 deletion strains, with specific analysis of:

    • Alternative splicing events using computational tools like rMATS or VAST-TOOLS

    • Intron retention patterns and exon skipping frequencies

    • Differential gene expression profiles

  • Direct RNA-protein interaction studies:

    • Implement CLIP-seq (Cross-Linking Immunoprecipitation followed by sequencing) to identify RNA sequences directly bound by CSN-12

    • Perform RNA Immunoprecipitation (RIP) followed by qRT-PCR for candidate transcripts

    • Use in vitro binding assays with recombinant CSN-12 and synthetic RNA

  • Splicing factor interactome mapping:

    • Conduct co-immunoprecipitation with CSN-12 followed by mass spectrometry to identify splicing-related interaction partners

    • Perform reciprocal IP experiments with N. crassa homologs of yeast splicing factors SMB1, SMX2, and SMX3

    • Implement BiFC (Bimolecular Fluorescence Complementation) to visualize interactions in vivo

  • Functional splicing assays:

    • Develop reporter constructs with intron-containing genes to monitor splicing efficiency

    • Perform in vitro splicing assays with extracts from wild-type and csn-12 mutants

    • Analyze spliceosome assembly and dynamics using glycerol gradient fractionation

  • Localization studies:

    • Examine co-localization of fluorescently tagged CSN-12 with splicing speckles or other RNA processing bodies

    • Investigate nuclear-cytoplasmic distribution under different conditions

These complementary approaches would provide comprehensive insights into CSN-12's involvement in RNA processing and potentially uncover a novel functional link between the CSN complex and RNA metabolism.

How might structural studies advance our understanding of CSN-12 function within protein complexes?

Structural studies of CSN-12 and its interaction partners would significantly advance our understanding of its functional mechanisms. Based on the challenges encountered in crystallizing the Thp3-Csn12-Sem1 complex in yeast and the structural data available for related complexes , several promising approaches include:

Such structural insights would help explain how CSN-12 might bridge between the COP9 signalosome functions and RNA processing machinery, potentially revealing allosteric mechanisms or conformational changes that regulate its diverse functions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.